|
GMIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.477700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.820600E-03 |
| Normal-vs-Stage2 |
9.59659999999474E-05 |
| Normal-vs-Stage3 |
4.915500E-03 |
| Normal-vs-Stage4 |
4.177800E-03 |
| Stage1-vs-Stage2 |
4.984000E-03 |
| Stage1-vs-Stage3 |
6.500000E-01 |
| Stage1-vs-Stage4 |
3.751600E-01 |
| Stage2-vs-Stage3 |
3.681700E-02 |
| Stage2-vs-Stage4 |
2.563000E-01 |
| Stage3-vs-Stage4 |
6.056600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.123900E-03 |
| Normal-vs-AfricanAmerican |
1.749900E-02 |
| Normal-vs-Asian |
1.021820E-02 |
| Caucasian-vs-AfricanAmerican |
8.782200E-01 |
| Caucasian-vs-Asian |
9.501000E-01 |
| AfricanAmerican-vs-Asian |
9.151400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.004240E-02 |
| Normal-vs-Female |
1.819340E-03 |
| Male-vs-Female |
3.511800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.035520E-02 |
| Normal-vs-Age(41-60Yrs) |
5.794700E-04 |
| Normal-vs-Age(61-80Yrs) |
6.718500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.695600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.468200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.994800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.204800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.394800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.567500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.989640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.260400E-02 |
| Classical-VS-Follicular |
3.513600E-02 |
| Classical-VS-Other |
3.465200E-01 |
| Classical-VS-Normal |
8.418900E-03 |
| Tall-VS-Follicular |
4.099400E-01 |
| Tall-VS-Other |
8.589000E-01 |
| Tall-VS-Normal |
1.966680E-04 |
| Follicular-VS-Other |
7.780600E-01 |
| Follicular-VS-Normal |
4.408200E-04 |
| Other-VS-Normal |
1.109910E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.055200E-03 |
| Normal-vs-N1 |
2.580000E-04 |
| N0-vs-N1 |
4.738100E-02 |
|
|
